| Dr Lawrenta Okojie, DNP, MSN-ED, BSN, RN | |
|
14908 Taryn Lea Ct, Accokeek, MD 20607-2610 | |
| (301) 526-7534 | |
| Not Available |
| Full Name | Dr Lawrenta Okojie |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Informatics |
| Location | 14908 Taryn Lea Ct, Accokeek, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700542057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SI0800X | Clinical Nurse Specialist - Informatics | RN1021765 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lawrenta Okojie, DNP, MSN-ED, BSN, RN 14908 Taryn Lea Ct, Accokeek, MD 20607-2610 Ph: () - | Dr Lawrenta Okojie, DNP, MSN-ED, BSN, RN 14908 Taryn Lea Ct, Accokeek, MD 20607-2610 Ph: (301) 526-7534 |
News Archive
Scientific research is increasingly showing strong links between spending too much time sitting and the development of severe long and short term health problems.
Serious falls are more than twice as likely in older men who take medicines with anti-cholinergic properties - according to new research from the University of East Anglia.
Seven of 10 adults with appendicitis can safely avoid surgical removal of their appendix (appendectomy) for at least several months by receiving a course of antibiotics, according to early results of a U.S. study that is the largest to compare use of these drugs alone versus an operation for appendicitis treatment.
Queensland Institute of Medical Research scientists have identified a new link between strong period pain experienced in adolescence and early adulthood and the risk of endometriosis.
Halozyme Therapeutics has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Cumulase for the treatment of oocytes to facilitate certain in vitro fertilization (IVF) procedures. The active pharmaceutical ingredient in Cumulase is the first and only recombinant human hyaluronidase approved in the United States for cumulus removal in the IVF process.
› Verified 2 days ago
Musu Turay, CRNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 203 Mattawoman Way, Accokeek, MD 20607 Phone: 301-542-3396 |